Pharmaceutical segment is expected to welcome the theme of the opportunity to enter the industry in -mine_清翼

Pharmaceutical segments are expected to meet the theme of opportunity in vitro diagnostics industry into the high boom period Sina App: Live on-line blogger to guide you with entries you earn can make you my "red week" author Liu Xiaoxu 9~10 every month for you, and Nobel Lasker relates to medicine international awards will be issued during this period therefore, A stock market will set off a wave of speculation in the market of pharmaceutical stocks. With the progress of science and technology and policy guidance, the pharmaceutical industry has obvious internal differentiation, the emerging pharmaceutical industry in vitro diagnostic and blood products represented in the capital market more and more attention to the funds, expected two sector leading companies are expected to get a chance in the four quarter. The "Nobel" issue is expected to lead to medical market according to the theme Nobel Committee official website news, the 2016 Nobel awards ceremony will be issued in succession in October 3rd, the prize in physiology or medicine will be the first to publish. As the most authoritative and influential global science and technology award, the Nobel prize will be announced on the development of high-tech fields involving biological medicine to have a significant impact, while the A shares market will also set off a wave of speculation boom related concepts. As of 2015, China pharmacologist Tu lady for the discovery of the antimalarial drug artemisinin and won the Nobel prize in physiology or medicine, making the market funds borrow at the time of the A stock market set off a round of biological medicine and gene sequencing speculation boom, especially gene sequencing pharmaceutical segments, the plate in the middle of September 2015 to the end of the year the overall increase of more than 20%. In September 13th this year, known as the "Nobel prize weathervane Lasker Awards in the United States announced," the study of human and animal cells perception mechanism of oxygen content for basic medical research award "," copy "hepatitis C system and drug development research" won the award for clinical medical research. It is understood that the Lasker Award is the Nobel prize in physiology or medicine weathervane. From the history of "prize" and "the Nobel award winning time interval, the same year the probability of winning the highest, the announcement of the Lasker Awards have a greater probability of winning this year’s Nobel prize. In this award, three scientists have elucidated the basic principle of the cellular oxygen content at the molecular level, revealing an important signal mechanism. Hypoxia inducible factor (Hif) is a transcription factor of hypoxia related genes. In the hypoxic environment, easily lead to a variety of diseases, such as cancer, myocardial infarction, stroke and peripheral vascular disease, found this signaling mechanism for future drug development related diseases will have important guiding significance. Similarly, the Lasker clinical medical award this year to the most important anti HCV drugs "Sophie Bouvet" and "Harvoni" (Sophie Bouvet compound, C 2 generation), than previously expected. At present, the drug price is too expensive, the market needs the birth of its generic drugs. At present, China Sea sea, Cologne, Melbourne and other companies have approved to carry out clinical trials. In June 28th, the latest anti HCV drugs Gilead Epclusa (C three) received FDA approval for the treatment of type 1~6 hepatitis C, is expected to top two generation drug form theory相关的主题文章: